Is Cyteir Therapeutics Inc (CYT) a Good Choice in Biotechnology Thursday?

Thursday, January 11, 2024 10:46 AM | InvestorsObserver Analysts

Mentioned in this article

Is Cyteir Therapeutics Inc (CYT) a Good Choice in Biotechnology Thursday?

Cyteir Therapeutics Inc (CYT) is around the top of the Biotechnology industry according to InvestorsObserver. CYT received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Cyteir Therapeutics Inc also achieved a score of 84 in the Biotechnology industry, putting it above 84 percent of Biotechnology stocks. Biotechnology is ranked 35 out of the 148 industries.

CYT has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on CYT!

See Full CYT Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cyteir Therapeutics Inc Stock Today?

Cyteir Therapeutics Inc (CYT) stock has risen 1.97% while the S&P 500 is lower by -0.34% as of 10:45 AM on Thursday, Jan 11. CYT has gained $0.06 from the previous closing price of $3.04 on volume of 167,001 shares. Over the past year the S&P 500 is up 20.10% while CYT has gained 92.55%. CYT lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for Cyteir Therapeutics Inc stock.